logo
Sign in

SPR THERAPEUTICS, INC.

Cleveland, OH · Founded 2009 · Medtech · Acquired

Percutaneous peripheral nerve stimulation (PNS) system for post-surgical pain management

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · sprtherapeutics.com

Sector
Medtech
Headquarters
Cleveland, OH
Founded
2009
Latest Form D
$25.6M, Feb 2024
Total capital
$82.5M
Federal grants
$11.7M
11 awards · 2015–2023
Rank in peer group#220 of 538
Private capital raised
$70.7M
8 Form D · last Feb 2024
33 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
20
20 pending · first 2024
Rank in peer group#2 of 538

Capital timeline

2011201320152017201920212023FEDERAL ↑EQUITY ↓Cumulative $86.2M$1.4M$981K$954K$3M$1.1M$903K2nd Form D$3.8M7th Form D$20M
2011201520192023FEDERAL ↑EQUITY ↓Cumulative $86.2M$1.4M$981K$3M$1.1M

Latest events

  • Private capital raisedForm D · SEC · 8th filing$25.6M
  • Federal grantHealth and Human S · Phase II · Electrical stimulation to reduce pain and improve function after knee replacement$903K
  • Federal grantHealth and Human S · Phase II · Electrical stimulation to reduce pain and improve function after knee replacement$1.1M
  • Federal grantHealth and Human S · Phase II · Electrical stimulation to reduce pain and improve function after knee replacement$3M
  • Federal grantHealth and Human S · Phase II · Electrical stimulation to reduce pain and improve function after knee replacement$954K
  • Private capital raisedForm D · SEC · 7th filing$20M
  • Private capital raisedForm D · SEC · 6th filing$8M
  • Private capital raisedForm D · SEC · 5th filing$15M
  • Private capital raisedForm D · SEC · 4th filing$582K
  • Private capital raisedForm D · SEC · 3rd filing$519K
  • Offering registeredForm D · SEC · 2nd filing$3.8M
  • Private capital raisedForm D · SEC · 1st filing$1.0M
Show 7 earlier federal awards
  • Federal grantDefense · Phase II · Development of a Specialized Miniature Stimulator System for Non-Opioid Pain Relief$981K
  • Federal grantHealth and Human S · Phase II · Electrical stimulation to reduce pain and improve function after knee replacement$848K
  • Federal grantHealth and Human S · Phase II · Electrical stimulation to reduce pain and improve function after knee replacement$873K
  • Federal grantHealth and Human S · Phase II · Peripheral nerve stimulation for amputee pain$720K
  • Federal grantHealth and Human S · Phase II · Electrical stimulation to reduce pain and improve function after knee replacement$210K
  • Federal grantHealth and Human S · Phase II · Miniature Stimulator for Temporary Therapies$1.4M
  • Federal grantHealth and Human S · Phase II · Peripheral nerve stimulation for amputee pain$737K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#220 · top 41%
  • Granted patents#2 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Maria BennettResearcherExecutive OfficerLinked by $1.4M in grants as PI
  • Ben J. AustinExecutive OfficerNamed in SEC Form D filings
  • Dave C. YoungbergExecutive OfficerNamed in SEC Form D filings
  • Geoffrey B. ThropeDirectorNamed in SEC Form D filings
  • Josh A. BoggsExecutive OfficerNamed in SEC Form D filings
  • Len CosentinoDirectorNamed in SEC Form D filings
Show all 16 people
  • Leonard M. CosentinoDirectorNamed in SEC Form D filings
  • Les C. VinneyDirectorNamed in SEC Form D filings
  • Marilyn A. EiseleExecutive OfficerNamed in SEC Form D filings
  • Mark C. StulzExecutive OfficerNamed in SEC Form D filings
  • Michael C. ChuisanoDirectorNamed in SEC Form D filings
  • Nicholas J. ValerianiDirectorNamed in SEC Form D filings
  • Patricia C. ShraderDirectorNamed in SEC Form D filings
  • Ralph Della Ratta, Jr.DirectorNamed in SEC Form D filings
  • Robert B. BlankenshipDirectorNamed in SEC Form D filings
  • Warren C. GrillDirectorNamed in SEC Form D filings

What it has protected

USPTO · 20 granted of 40
  • New patentRecharging Base For An Electrical StimulatorUSPTOUS D1,150,494
  • PendingFracture Resistant Stimulation LeadUSPTOApplication 19652112
  • PendingStimulation Lead Connection SystemUSPTOApplication 19532340
Show all 40 patent records

Related companies, and why

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .